Latest filing published 27 May 2015 for Valeant Pharmaceuticals International, Inc..
No signal scores available.
Anders Lonner is a declared insider at 2 companies; the most frequent names are Valeant Pharmaceuticals International and Valeant Pharmaceuticals International, Inc. The record holds 15 filings, for trades running from 7 January 2009 to 26 May 2015.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 27 May 2015 came the latest disclosure, a share grant in Valeant Pharmaceuticals International, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations